Salmeterol (Serevent) asthma trial halted early

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 6, 2003, Pages 738-

  Wooltorton, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; FLUTICASONE; PLACEBO; SALMETEROL XINAFOATE;

ARTIFICIAL VENTILATION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DATA ANALYSIS; DEATH; DRUG SAFETY; EMERGENCY WARD; ETHNOLOGY; HOSPITAL ADMISSION; HUMAN; INTUBATION; LUNG EDEMA; RESPIRATORY TRACT DISEASE; SHORT SURVEY; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 0037453104     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Serevent [product monograph]. In: Compendium of pharmaceuticals and specialties. Ottawa: Canadian Pharmacists Association; 2002. p. 1540-2.
2. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346:1631-6.
3. 2-agonists be prescribed as initial maintenance treatment for asthma? [editorial] CMAJ 2002;167(9):1008-9.
4. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993;306:1034-7.
5. Bunney R. Study too small to detect increase in deaths [letter]. BMJ 1993;306:1610.
6. Finkelstein FN. Risks of salmeterol? [letter] N Engl J Med 1994;331:1314.
7. Mann RD, Kubota K, Pearce G, Wilton L. Salmeterol: a study by prescription-event monitoring in a UK cohort of 15 407 patients. J Clin Epidemiol 1996;49:247-50.
8. Olopade CO, Rubinstein I. Salmeterol xinafoate vs albuterol in asthma: Was race a factor? JAMA 1994;272:1576.
9. Akinbami LJ, LaFleur BJ, Scoendorf KC. Racial and income disparities in childhood asthma in the United States. Ambul Pediatr 2002;2:382-7.
10. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P, on behalf of the Canadian Asthma Consensus Group. Summary of recommendations from the Canadian Asthma Consensus Report, 1999. CMAJ 1999;161(11 Suppl):S1-12.